BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25863260)

  • 1. Heparanase stimulates chondrogenesis and is up-regulated in human ectopic cartilage: a mechanism possibly involved in hereditary multiple exostoses.
    Huegel J; Enomoto-Iwamoto M; Sgariglia F; Koyama E; Pacifici M
    Am J Pathol; 2015 Jun; 185(6):1676-85. PubMed ID: 25863260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.
    Huegel J; Mundy C; Sgariglia F; Nygren P; Billings PC; Yamaguchi Y; Koyama E; Pacifici M
    Dev Biol; 2013 May; 377(1):100-12. PubMed ID: 23458899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.
    Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M
    J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice.
    Sinha S; Mundy C; Bechtold T; Sgariglia F; Ibrahim MM; Billings PC; Carroll K; Koyama E; Jones KB; Pacifici M
    PLoS Genet; 2017 Apr; 13(4):e1006742. PubMed ID: 28445472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
    Pacifici M
    Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.
    Mundy C; Yang E; Takano H; Billings PC; Pacifici M
    J Biol Chem; 2018 May; 293(20):7703-7716. PubMed ID: 29622677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHP2 regulates chondrocyte terminal differentiation, growth plate architecture and skeletal cell fates.
    Bowen ME; Ayturk UM; Kurek KC; Yang W; Warman ML
    PLoS Genet; 2014; 10(5):e1004364. PubMed ID: 24875294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.
    Zak BM; Schuksz M; Koyama E; Mundy C; Wells DE; Yamaguchi Y; Pacifici M; Esko JD
    Bone; 2011 May; 48(5):979-87. PubMed ID: 21310272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.
    Huegel J; Sgariglia F; Enomoto-Iwamoto M; Koyama E; Dormans JP; Pacifici M
    Dev Dyn; 2013 Sep; 242(9):1021-32. PubMed ID: 23821404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.
    Trebicz-Geffen M; Robinson D; Evron Z; Glaser T; Fridkin M; Kollander Y; Vlodavsky I; Ilan N; Law KF; Cheah KS; Chan D; Werner H; Nevo Z
    Int J Exp Pathol; 2008 Oct; 89(5):321-31. PubMed ID: 18452536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HhAntag, a Hedgehog Signaling Antagonist, Suppresses Chondrogenesis and Modulates Canonical and Non-Canonical BMP Signaling.
    Mundy C; Bello A; Sgariglia F; Koyama E; Pacifici M
    J Cell Physiol; 2016 May; 231(5):1033-44. PubMed ID: 26363135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses.
    Legeai-Mallet L; Rossi A; Benoist-Lasselin C; Piazza R; Mallet JF; Delezoide AL; Munnich A; Bonaventure J; Zylberberg L
    J Bone Miner Res; 2000 Aug; 15(8):1489-500. PubMed ID: 10934647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cartilage-specific overexpression of ERRĪ³ results in Chondrodysplasia and reduced chondrocyte proliferation.
    Cardelli M; Zirngibl RA; Boetto JF; McKenzie KP; Troy TC; Turksen K; Aubin JE
    PLoS One; 2013; 8(12):e81511. PubMed ID: 24349082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate deficiency leads to hypertrophic chondrocytes by increasing bone morphogenetic protein signaling.
    Kawashima K; Ogawa H; Komura S; Ishihara T; Yamaguchi Y; Akiyama H; Matsumoto K
    Osteoarthritis Cartilage; 2020 Nov; 28(11):1459-1470. PubMed ID: 32818603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of the EXT2 gene in developing chondrocytes enhances the synthesis of heparan sulfate and bone formation in mice.
    Morimoto K; Shimizu T; Furukawa K; Morio H; Kurosawa H; Shirasawa T
    Biochem Biophys Res Commun; 2002 Apr; 292(4):999-1009. PubMed ID: 11944914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.
    Sgariglia F; Candela ME; Huegel J; Jacenko O; Koyama E; Yamaguchi Y; Pacifici M; Enomoto-Iwamoto M
    Bone; 2013 Nov; 57(1):220-31. PubMed ID: 23958822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.
    Brown AJ; Alicknavitch M; D'Souza SS; Daikoku T; Kirn-Safran CB; Marchetti D; Carson DD; Farach-Carson MC
    Bone; 2008 Oct; 43(4):689-99. PubMed ID: 18589009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate abnormalities in exostosis growth plates.
    Hecht JT; Hall CR; Snuggs M; Hayes E; Haynes R; Cole WG
    Bone; 2002 Jul; 31(1):199-204. PubMed ID: 12110435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.
    Mooij HL; Cabrales P; Bernelot Moens SJ; Xu D; Udayappan SD; Tsai AG; van der Sande MA; de Groot E; Intaglietta M; Kastelein JJ; Dallinga-Thie GM; Esko JD; Stroes ES; Nieuwdorp M
    J Am Heart Assoc; 2014 Dec; 3(6):e001274. PubMed ID: 25468659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.